Invention Grant
- Patent Title: Method for binding active agents to activated autologous blood nosodes and device for performing said method
-
Application No.: US15537726Application Date: 2015-09-10
-
Publication No.: US10596258B2Publication Date: 2020-03-24
- Inventor: Claudia Bettina Klein
- Applicant: YENO FOUNDATION AG
- Applicant Address: NL Amsterdam
- Assignee: Yeno Awareness BV
- Current Assignee: Yeno Awareness BV
- Current Assignee Address: NL Amsterdam
- Agency: Frost Brown Todd LLP
- Priority: EP20140184416 20140911
- International Application: PCT/EP2015/001827 WO 20150910
- International Announcement: WO2016/037705 WO 20160317
- Main IPC: A61K41/00
- IPC: A61K41/00 ; A61K47/64 ; B01L1/00 ; B01L9/06 ; B01L3/00 ; A61K31/417 ; A61K33/10 ; A61K33/24 ; A61K33/42 ; A61K39/085 ; A61K33/16 ; A61K39/245 ; A61K39/12 ; A61K33/06 ; A61K33/28

Abstract:
A method for binding an active substance or an active agent to an activated autologous blood nosode comprises a) dissolving blood of a patient in an aqueous or aqueous/ethanol medium or triturating blood of a patient with an excipient approved for globules according to HAB [Homeopathic Pharmacopoeia] in order to obtain a first mixture; b) activating the first mixture by exposure of the first mixture to magnetic pulses having frequencies of the magnet field periods within a range from approximately 0.01 to approximately 20,0000 Hz and maximum field strengths of 50 μT; c) adding an active substance and/or active agent or one or more active substances and/or active agents to the activated first mixture in order to obtain a second mixture; d) succussing the second mixture by mechanical action, wherein steps c) and d) are conducted under the continuous action of the magnetic pulses, and wherein steps c) and d) can be repeated once or several times; and e) activating the succussed second mixture by further continuous exposure to the magnetic pulses and by irradiation with visible light of changing colors produced by LEDs into the succussed second mixture, whereby an increase of the binding capacity of the HSA [human serum albumin] in the blood to the active substance(s) and/or to at least some of the active agent or active agents is achieved. A device for performing the method is also described.
Public/Granted literature
Information query